References analysis of the Wikipedia article "Hans-Georg Rammensee" in the English version

doi.org

Schuster, Heiko; Peper, Janet K.; Bösmüller, Hans-Christian; Röhle, Kevin; Backert, Linus; Bilich, Tatjana; Ney, Britta; Löffler, Markus W.; Kowalewski, Daniel J.; Trautwein, Nico; Rabsteyn, Armin; Engler, Tobias; Braun, Sabine; Haen, Sebastian P.; Walz, Juliane S.; Schmid-Horch, Barbara; Brucker, Sara Y.; Wallwiener, Diethelm; Kohlbacher, Oliver; Fend, Falko; Rammensee, Hans-Georg; Stevanović, Stefan; Staebler, Annette; Wagner, Philipp (14 November 2017). "The immunopeptidomic landscape of ovarian carcinomas". Proceedings of the National Academy of Sciences of the United States of America. 114 (46): E9942–E9951. Bibcode:2017PNAS..114E9942S. doi:10.1073/pnas.1707658114. PMC 5699044. PMID 29093164.

Kowalewski, Daniel J.; Schuster, Heiko; Backert, Linus; Berlin, Claudia; Kahn, Stefan; Kanz, Lothar; Salih, Helmut R.; Rammensee, Hans-Georg; Stevanovic, Stefan; Stickel, Juliane Sarah (13 January 2015). "HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)". Proceedings of the National Academy of Sciences of the United States of America. 112 (2): E166–175. Bibcode:2015PNAS..112E.166K. doi:10.1073/pnas.1416389112. PMC 4299203. PMID 25548167.

"Correction to Supporting Information for Kowalewski et al., HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)". Proceedings of the National Academy of Sciences of the United States of America. 112 (45): E6258–6260. 10 November 2015. Bibcode:2015PNAS..112E6258.. doi:10.1073/pnas.1519136112. PMC 4653161. PMID 26527660.

"Correction for Kowalewski et al., HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)". Proceedings of the National Academy of Sciences of the United States of America. 112 (45): E6254–6256. 10 November 2015. Bibcode:2015PNAS..112E6254.. doi:10.1073/pnas.1519135112. PMC 4653212. PMID 26483495.

Gubin, Matthew M.; Zhang, Xiuli; Schuster, Heiko; Caron, Etienne; Ward, Jeffrey P.; Noguchi, Takuro; Ivanova, Yulia; Hundal, Jasreet; Arthur, Cora D.; Krebber, Willem-Jan; Mulder, Gwenn E.; Toebes, Mireille; Vesely, Matthew D.; Lam, Samuel S.K.; Korman, Alan J.; Allison, James P.; Freeman, Gordon J.; Sharpe, Arlene H.; Pearce, Erika L.; Schumacher, Ton N.; Aebersold, Ruedi; Rammensee, Hans-Georg; Melief, Cornelis J. M.; Mardis, Elaine R.; Gillanders, William E.; Artyomov, Maxim N.; Schreiber, Robert D. (27 November 2014). "Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens". Nature. 515 (7528): 577–581. Bibcode:2014Natur.515..577G. doi:10.1038/nature13988. PMC 4279952. PMID 25428507.

Britten, Cedrik M; Singh-Jasuja, Harpreet; Flamion, Bruno; Hoos, Axel; Huber, Christoph; Kallen, Karl-Josef; Khleif, Samir N; Kreiter, Sebastian; Nielsen, Michaela; Rammensee, Hans-Georg; Sahin, Ugur; Hinz, Thomas; Kalinke, Ulrich (8 October 2013). "The regulatory landscape for actively personalized cancer immunotherapies". Nature Biotechnology. 31 (10): 880–882. doi:10.1038/nbt.2708. PMID 24104749. S2CID 19069323.

Hoerr, I.; Obst, R.; Rammensee, H. G.; Jung, G. (1 January 2000). "In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies". European Journal of Immunology. 30 (1): 1–7. doi:10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-#. PMID 10602021. S2CID 196606232.

Rammensee, H.; Bachmann, J.; Emmerich, N. P.; Bachor, O. A.; Stevanović, S. (1 November 1999). "SYFPEITHI: database for MHC ligands and peptide motifs". Immunogenetics. 50 (3–4): 213–219. doi:10.1007/s002510050595. PMID 10602881. S2CID 1407069.

Falk, K.; Rötzschke, O.; Stevanović, S.; Jung, G.; Rammensee, H. G. (23 May 1991). "Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules". Nature. 351 (6324): 290–296. Bibcode:1991Natur.351..290F. doi:10.1038/351290a0. PMID 1709722. S2CID 4342714.

Deres, K.; Schild, H.; Wiesmüller, K. H.; Jung, G.; Rammensee, H. G. (30 November 1989). "In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine". Nature. 342 (6249): 561–564. Bibcode:1989Natur.342..561D. doi:10.1038/342561a0. PMID 2586628. S2CID 4316816.

harvard.edu

ui.adsabs.harvard.edu

nih.gov

pubmed.ncbi.nlm.nih.gov

Weinschenk, Toni; Gouttefangeas, Cécile; Schirle, Markus; Obermayr, Florian; Walter, Steffen; Schoor, Oliver; Kurek, Raffael; Loeser, Wolfgang; Bichler, Karl-Horst; Wernet, Dorothee; Stevanović, Stefan; Rammensee, Hans-Georg (15 October 2002). "Integrated functional genomics approach for the design of patient-individual antitumor vaccines". Cancer Research. 62 (20): 5818–5827. PMID 12384544.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

uni-tuebingen.de

Hans-Georg Rammensee (English Wikipedia)

bayer-foundations.com

curevac.com

dfg.de

dkfz.de

doi.org

europa.eu

cordis.europa.eu

harvard.edu

ui.adsabs.harvard.edu

immatics.com

immunology-tuebingen.de

jung-stiftung.de

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

robert-koch-stiftung.de

semanticscholar.org

api.semanticscholar.org

synimmune.de

uni-frankfurt.de

uni-tuebingen.de

web.archive.org